Patent details

EP2307002 Title: COMBINATIONS OF SAPACITABINE OR CNDAC WITH DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE

Basic Information

Publication number:
EP2307002
PCT Application Number:
PCT/GB/2009/001418
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097619548
PCT Publication Number:
WO/2009/150405
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF SAPACITABINE OR CNDAC WITH DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE
French Title of Invention:
COMBINAISON DE SAPACITABINE OU CNDAC ET D'INHIBITEURS D'ADN METHYLTRANSFERASE TELS QUE LA DECITABINE ET LA PROCAÏNE
German Title of Invention:
KOMBINATIONEN VON SAPACITABIN ODER CNDAC MIT DNA-METHYLTRANSFERASE-INHIBITOREN WIE DECITABIN UND PROCAIN
SPC Number:

Dates

Filing date:
05/06/2009
Grant date:
02/01/2013
EP Publication Date:
02/01/2013
PCT Publication Date:
17/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/04/2011
EP B1 Publication Date:
02/01/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/06/2013
Expiration date:
05/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/03/2013
 
 

Name:
Cyclacel Limited
Address:
411 Tower Bridge Business Centre 46-48 East Smithfield, London E1W 1AW, United Kingdom (GB)

Inventor

1

Name:
MACKAY Ruth
Address:
United Kingdom (GB)

2

Name:
FLEMING Ian, Neil
Address:
United Kingdom (GB)

3

Name:
GREEN Simon, Richard
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0810552
Priority Date:
09/06/2008
Priority Country:
United Kingdom (GB)

2

Priority Number:
0906696
Priority Date:
17/04/2009
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/245;
Filing date Document type Number of pages